Novartis AG
NVS Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Insiders
Institutions
Government
Ownership
$NVS is featured in our Shelley Moore Capito strategy.
See All StrategiesIncome
Balance Sheet
Cash Flow
NVS Income Statement
NVS Balance Sheet
NVS Cash Flow
Recent trades of NVS by members of U.S. Congress
NVS Stock Insider Trading Activity
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
NVS Stock Institutional Owners
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
NVS Derivatives Institutional Owners
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by NVS's directors and management
Government lobbying spending instances
-
$40,000 Feb 04, 2003 Issue: Agriculture
Estimated quarterly lobbying spending
U.S. Patents
New patents grants
-
Patent Title: Protein solution formulation containing high concentration of an anti-vegf antibody Apr. 02, 2024
-
Patent Title: Fibroblast growth factor-21-fc fusion proteins Apr. 02, 2024
-
Patent Title: Treatment of autoimmune disease in a patient receiving additionally a beta-blocker Apr. 02, 2024
-
Patent Title: Entpd2 antibodies, combination therapies, and methods of using the antibodies and combination therapies Mar. 26, 2024
-
Patent Title: Bcma chimeric antigen receptors and uses thereof Mar. 26, 2024
-
Patent Title: Hepatitis b antibodies Mar. 19, 2024
-
Patent Title: Labeled inhibitors of prostate specific membrane antigen (psma) as agents for the treatment of prostate cancer Mar. 19, 2024
-
Patent Title: Triazolopyrimidine compounds and uses thereof Mar. 19, 2024
-
Patent Title: Antibody-cytokine engrafted proteins and methods of use for immune related disorders Mar. 19, 2024
-
Patent Title: Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapy Mar. 05, 2024
-
Patent Title: Methyl (r)-2-(fluoromethyl)-5-oxo-4-phenyl-4,5,6,7-tetrahydro-1h-cyclopenta[b]pyridine-3-carboxylate and methyl (r)-2-(fluoromethyl)-5-oxo-4-phenyl-1,4,5,7-tetrahydrofuro[3,4-b]pyridine-3-carboxylate as cav1.2 activators Mar. 05, 2024
-
Patent Title: Flow-through paramagnetic particle-based cell separation and paramagnetic particle removal Feb. 27, 2024
-
Patent Title: Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infections Feb. 27, 2024
-
Patent Title: Pyridine and pyrazine derivative for the treatment of chronic bronchitis Feb. 27, 2024
-
Patent Title: Nucleic acid molecules encoding chimeric antigen receptors comprising a cd20 binding domain Feb. 27, 2024
-
Patent Title: Compounds and compositions for inhibiting the activity of shp2 Feb. 20, 2024
-
Patent Title: Methods for improving the efficacy and expansion of chimeric antigen receptor-expressing cells Feb. 13, 2024
-
Patent Title: Solid forms of n-(4-fluoro-3-(6-(3-methylpyridin-2-yl)-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)phenyl)-2,4-dimethyloxazole-5-carboxamide Feb. 06, 2024
-
Patent Title: Bicyclic compounds and their uses Jan. 23, 2024
-
Patent Title: Mrna-mediated immunization methods Jan. 23, 2024
-
Patent Title: Use of mavoglurant in the reduction of cocaine use or in preventing relapse into cocaine use Jan. 23, 2024
-
Patent Title: Manufacture of compounds and compositions for inhibiting the activity of shp2 Jan. 16, 2024
-
Patent Title: Method of treating cancer by administering immune effector cells expressing a chimeric antigen receptor comprising a cd20 binding domain Jan. 16, 2024
-
Patent Title: Optimized lentiviral transfer vectors and uses thereof Jan. 09, 2024
-
Patent Title: Treatment of cancer using humanized anti-egfrviii chimeric antigen receptor Jan. 09, 2024
-
Patent Title: Formulations of (s)-3-amino-6-methoxy-n-(3,3,3-trifluoro-2-hydroxy-2-methylpropyl)-5-(trifluoromethyl)picolinamide Jan. 09, 2024
-
Patent Title: Humanization of rabbit antibodies using a universal antibody framework Jan. 02, 2024
-
Patent Title: Compositions and methods for immunooncology Dec. 26, 2023
-
Patent Title: Method for preparing granules Dec. 19, 2023
-
Patent Title: Method of treating structural and/or functional cardiac abnormalities by administering an anti-actrii receptor antibody Dec. 05, 2023
-
Patent Title: Ckit antibody drug conjugates Dec. 05, 2023
-
Patent Title: 3-(5-amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof Dec. 05, 2023
-
Patent Title: Antibody molecules to pd-1 and uses thereof Nov. 28, 2023
-
Patent Title: 2-azaspiro[3.4]octane derivatives as m4 agonists Nov. 21, 2023
-
Patent Title: Micro-droplet delivery device and methods Nov. 21, 2023
-
Patent Title: Cyclic tetramer compounds as proprotein convertase subtilisin/kexin type 9 (pcsk9) inhibitors for the treatment of metabolic disorders Nov. 14, 2023
-
Patent Title: Selection vectors and methods of selecting eukaryotic host cells Nov. 07, 2023
-
Patent Title: Nmda receptor modulators and uses thereof Nov. 07, 2023
-
Patent Title: Methods of treating fgf21-associated disorders Oct. 31, 2023
-
Patent Title: Pharmaceutical products and stable liquid compositions of il-17 antibodies Oct. 31, 2023
-
Patent Title: Pyrazolopyridine derivatives and uses thereof Oct. 17, 2023
-
Patent Title: Sacubitril calcium salts Oct. 17, 2023
-
Patent Title: Anti-cd40 antibodies for use in prevention of graft rejection Oct. 10, 2023
-
Patent Title: Antibodies to pmel17 and conjugates thereof Oct. 10, 2023
-
Patent Title: Compounds and compositions for treating conditions associated with nlrp activity Sep. 19, 2023
-
Patent Title: Dosage regimen of an s1p receptor modulator Sep. 19, 2023
-
Patent Title: Compounds and compositions for inducing chondrogenesis Sep. 12, 2023
-
Patent Title: Fatty acids and their use in conjugation to biomolecules Sep. 12, 2023
-
Patent Title: Compounds and compositions for treating solid tumors by intratumoral administration Sep. 12, 2023
-
Patent Title: Biomarkers predictive of cytokine release syndrome Sep. 05, 2023
Government Contracts
Federal grants, loans, and purchases
Government Contracts
Estimated quarterly amount awarded from public contracts
WallStreetBets
Number of mentions of NVS in WallStreetBets Daily Discussion
NVS News
Recent insights relating to NVS
CNBC Recommendations
Recent picks made for NVS stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in NVS
NVS Top Shareholders
|
Shareholder
|
Shares Held
|
|---|
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
NVS Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view NVS Smart Score
Score Breakdown
Bull Case vs Bear Case
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
Bulls Say:
The Bulls Say summary highlights positive aspects of the stock.
Bears Say:
The Bears Say summary points out potential risks and negative aspects of the stock.
Show More